Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 2/20 | 0.48 |
| ▸ | BRD4 | O60885 | 3/20 | 0.48 |
| ▸ | KDM4A | O75164 | 1/20 | 0.46 |
| ▸ | GLS | O94925 | 3/20 | 0.45 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.45 |
| ▸ | ACACB | O00763 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | ACACA | Q13085 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | NQO2 | P16083 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.42 |
| ▸ | CKS1B | P61024 | 1/20 | 0.41 |
| ▸ | SKP1 | P63208 | 1/20 | 0.41 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | CTSS | P25774 | 1/20 | 0.41 |
| ▸ | CTSK | P43235 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24300007 | 0.83 | BRD4 (0.56) | NAMPTBRD4KDM4AGLSCREBBP | |
| SCHEMBL31755970 | 0.81 | BRD4 (0.49) | NAMPTBRD4KDM4AGLSCREBBP | |
| SCHEMBL4402738 | 0.81 | BRD4 (0.49) | NAMPTBRD4KDM4AGLSCREBBP | |
| SCHEMBL24299843 | 0.80 | MAPK1 (0.38) | CREBBP | |
| SCHEMBL18664426 | 0.80 | HDAC1 (0.60) | BRD4KDM4AGLSCREBBPHDAC1 | |
| SCHEMBL30504293 | 0.80 | HDAC1 (0.56) | NAMPTBRD4KDM4AGLSCREBBP | |
| SCHEMBL24000658 | 0.78 | PARP1 (0.53) | NAMPTBRD4GLSCREBBPCYP1A2 | |
| SCHEMBL24804174 | 0.78 | JAK3 (0.53) | BRD4CREBBP | |
| SCHEMBL301717 | 0.78 | PRMT6 (0.56) | NAMPTBRD4GLSCREBBPCYP3A4 | |
| SCHEMBL21455344 | 0.77 | CFD (0.47) | NAMPTBRD4GLSCREBBPACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220123235-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220123235-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | RER1, OXSR1, C1R | NAMPT 3827/4885BRD4 1134/4885KDM4A 3539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.